James O'Brien

James O'Brien

Financieel Directeur/CFO bij MESOBLAST LIMITED
59 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

James M.
O'Brien
is currently Chief Financial Officer at Mesoblast Ltd. since 2025.
Former positions include Chief Financial Officer at Faron Pharmaceuticals Oy from 2023 to 2024, Chief Financial Officer at Cognition Therapeutics, Inc. from 2019 to 2022, Executive Vice President-Finance at Enzo Biochem, Inc. from 2014 to 2019, Vice President & Corporate Controller at Allergan UC from 2010 to 2013, Vice President at Takeda Pharmaceutical Co., Ltd. in 2010, Chief Accounting Officer at U.S.I.
Holdings Corp.
from 2008 to 2009, Vice President & Controller at Aptuit LLC from 2005 to 2007, Chief Accountant at Purdue Pharma LP, and Principal at both Bristol Myers Squibb Co. and PricewaterhouseCoopers LLP.
Education includes undergraduate studies at George Washington University and an MBA from Fordham University.

Actieve functies van James O'Brien

BedrijvenFunctieBegin
MESOBLAST LIMITED Financieel Directeur/CFO 17-11-2025

Eerdere bekende functies van James O'Brien

BedrijvenFunctieEinde
FARON PHARMACEUTICALS OY Financieel Directeur/CFO 15-04-2024
COGNITION THERAPEUTICS, INC. Financieel Directeur/CFO 12-08-2022
ENZO BIOCHEM, INC. Corporate Officer/Principal 03-11-2019
ALLERGAN PLC Comptroller/Controller/Auditor -
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01-08-2010
Ervaring van James O'Brien in detail bekijken

Opleiding van James O'Brien

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

28

Eerstegraads connecties

13

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit13

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Health Technology

Consumer Services

Distribution Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. James O'Brien
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU